Name: XERS Income Statement - Xeris Biopharma Holdings. Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

XERS - Xeris Biopharma Holdings. Inc.

USD | NASDAQ | Healthcare

XERS Income Statement - Xeris Biopharma Holdings. Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20
Revenues
Revenues	83.1	85.8	74.4	71.5	60.1	60.1	54.3	48.1	40.6	-	48.3	38.0	-	33.1	29.7	25.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Revenues
Revenues	314.9	291.8	203.1	163.9	110.2	49.6	20.4
Cost of Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-
Operating Expenses
Research & Development	32.2	31.2	25.6	22.3	21.0	25.2	20.9
Selling General & Administrative	191.5	182.4	163.5	146.1	137.7
Operating Income
Operating Income	35.9	24.9	(33.6)	(44.0)	(81.9)	(115.2)	(83.5)
Non-Operating
Interest Income	4.8	4.7	5.3	4.8	2.6	0.3	3.0
Interest Expense	28.7	29.1	30.5	26.6	14.1	7.2	10.7
Tax & Net
Income Tax Expense	0.0	0.0	(2.3)	(1.2)	(1.4)	0.0	(0.1)
Net Income From Continuing Ops	12.0	0.6	(54.8)	(62.3)	(94.7)	(122.7)
Per Share
EPS Basic	0.07	0.00	(0.37)	(0.45)	(0.70)	(1.55)	-
EPS Diluted	0.07	0.00	(0.37)	(0.45)	(0.70)	(1.55)	-
Supplementary Data
EBITDA	-	26.2	(32.4)	(42.5)	(80.5)	(113.8)	(82.1)
EBIT	35.9	24.9	(33.6)	(44.0)	(81.9)	(115.2)	(83.5)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Income
Operating Income	7.9	16.8	6.7	4.5	(3.1)	1.7	(12.9)	(8.2)	(14.2)	-	(4.9)	(16.0)	-	(15.2)	(18.8)	(18.9)	(29.1)	(48.3)	(24.4)	(25.8)	(16.7)	-	(13.7)	-	-

Tax & Net
Income Tax Expense	0.0	0.0	0.0	0.0	0.0	0.0	(3.3)	0.7	0.3	-	(0.3)	(0.7)	-	(0.3)	(0.3)	(0.3)	(0.4)	0.0	0.0	0.0	0.0	-	0.0	-	-
Net Income From Continuing Ops	2.2	11.1	0.6	(1.9)	(9.2)	(5.1)	(15.7)	(15.0)	(19.0)	(13.4)	(12.2)	(19.8)	(16.8)	(12.9)	(21.8)	(26.2)	(33.7)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	2.2	11.1	0.6	(1.9)	(9.2)	(5.1)	(15.7)	(15.0)	(19.0)	(13.4)	(12.2)	(19.8)	(16.8)	(12.9)	(21.8)	(26.2)	(33.7)
Net Income Attributable To Parent	2.2	11.1	0.6	(1.9)	(9.2)	(5.1)	(15.7)	(15.0)	(19.0)	(13.4)	(12.2)	(19.8)	(16.8)	(12.9)	(21.8)	(26.2)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	2.2	11.1	0.6	(1.9)	(9.2)	(5.1)	(15.7)	(15.0)	(19.0)	(13.4)	(12.2)	(19.8)	(16.8)	(12.9)	(21.8)

Per Share
EPS Basic	0.01	-	0.00	(0.01)	(0.06)	-	(0.11)	(0.10)	(0.14)	-	(0.09)	(0.14)	-	-	(0.16)	(0.19)	(0.25)	-	(0.39)	(0.41)	(0.30)	-	-	-	-
EPS Diluted	0.01	-	0.00	(0.01)	(0.06)	-	(0.11)	(0.10)	(0.14)	-	(0.09)	(0.14)	-	-	(0.16)	(0.19)	(0.25)	-
Shares Basic	170.5	-	163.6	159.5	152.4	-	149.0	148.3	140.5	-	138.1	137.3	-	-	136.0	135.5	135.0	-
Shares Diluted	177.6	-	177.6	159.5	152.4	-	149.0	148.3	140.5	-	138.1	137.3	-	-	136.0	135.5	135.0	-

Supplementary Data
EBITDA	8.3	-	-	-	(2.8)	-	-	-	(13.9)	-	-	-	-	-	-	-	(28.8)	-	-	-	(16.4)	-	-	-	-
EBIT	7.9	16.8	6.7	4.5	(3.1)	1.7	(12.9)	(8.2)	(14.2)	-	(4.9)	(16.0)	-	(15.2)	(18.8)	(18.9)	(29.1)	(48.3)	(24.4)

Operating Expenses
Research & Development	8.8	7.9	7.5	8.1	7.8	6.1	5.9	5.8	7.8	-	5.0	6.1	-	5.0	6.0	3.7	6.3	10.1	5.7	5.4	4.0	-	3.9	-	-
Selling General & Administrative	53.1	47.5	46.5	44.4	44.0	40.1	45.0	40.0	38.4	-	37.3	37.6	-	34.4	34.5	33.0
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	0.3	-	-	-	0.3	-	-	-	0.3	-	-	-	-	-	-	-	0.3
Amortization of Intangibles	2.7	2.7	2.7	2.7	2.7	2.7	2.7	2.7	2.7	-	2.7	2.7	-	2.7	2.7	2.7	2.7
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Non-Operating
Interest Income	1.2	1.5	1.2	0.9	1.2	0.9	1.2	1.3	1.9	-	1.1	1.2	-	1.8	0.5	0.2	0.1	0.1	0.1	0.1	0.1	-	0.2	-	-
Interest Expense	6.9	7.2	7.3	7.4	7.3	7.7	7.8	8.0	7.0	-	6.8	6.5	-	3.1	4.0	3.4	3.5	1.8
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(5.7)	(5.7)	(6.1)	(6.4)	(6.1)	(6.8)	(6.2)	(6.1)	(4.4)	-	(7.6)	(4.5)	-	1.9	(3.4)	(7.6)	(5.0)
Pre-Tax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-